HomeMBX • NASDAQ
add
MBX Biosciences Inc
Previous close
$24.20
Day range
$21.62 - $26.15
Year range
$20.29 - $26.19
Market cap
693.61M USD
Avg Volume
138.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 16.66M | 108.04% |
Net income | -15.86M | -108.43% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -16.60M | -108.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 55.26M | — |
Total assets | 62.88M | — |
Total liabilities | 8.41M | — |
Total equity | 54.47M | — |
Shares outstanding | 15.83M | — |
Price to book | -3.92 | — |
Return on assets | -60.27% | — |
Return on capital | -67.00% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -15.86M | -108.43% |
Cash from operations | -13.27M | -79.79% |
Cash from investing | -7.89M | -139.52% |
Cash from financing | -1.76M | -377.76% |
Net change in cash | -22.92M | -273.36% |
Free cash flow | -8.54M | — |
About
Founded
2018
Headquarters
Website
Employees
36